These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 29219277

  • 21. Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancer.
    Kurahashi T, Miyake H, Furukawa J, Kumano M, Takenaka A, Fujisawa M.
    Int Urol Nephrol; 2010 Mar; 42(1):73-9. PubMed ID: 19449119
    [Abstract] [Full Text] [Related]

  • 22. Do we use the right criteria for determining the clinical significance of incidental prostate cancer at radical cystoprostatectomy?
    Gakis G, Stenzl A, Renninger M.
    Scand J Urol; 2013 Oct; 47(5):358-62. PubMed ID: 23078550
    [Abstract] [Full Text] [Related]

  • 23. Incidentally detected prostate cancer in cystoprostatectomy specimens.
    Kouriefs C, Fazili T, Masood S, Naseem MS, Mufti GR.
    Urol Int; 2005 Oct; 75(3):213-6. PubMed ID: 16215307
    [Abstract] [Full Text] [Related]

  • 24. [Functional and oncological outcome of salvage prostatectomy of locally recurrent prostate cancer following radiation therapy].
    Heidenreich A, Ohlmann C, Ozgür E, Engelmann U.
    Urologe A; 2006 Apr; 45(4):474-81. PubMed ID: 16465521
    [Abstract] [Full Text] [Related]

  • 25. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
    Capitanio U, Scattoni V, Freschi M, Briganti A, Salonia A, Gallina A, Colombo R, Karakiewicz PI, Rigatti P, Montorsi F.
    Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
    [Abstract] [Full Text] [Related]

  • 26. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.
    Damiano R, Di Lorenzo G, Cantiello F, De Sio M, Perdonà S, D'Armiento M, Autorino R.
    Eur Urol; 2007 Sep; 52(3):648-57. PubMed ID: 17600614
    [Abstract] [Full Text] [Related]

  • 27. Impact of Prostate Involvement on Outcomes in Patients Treated with Radical Cystoprostatectomy for Bladder Cancer.
    Moschini M, Shariat SF, Freschi M, Soria F, Abufaraj M, Gandaglia G, Dell'Oglio P, Mattei A, Damiano R, Salonia A, Montorsi F, Briganti A, Gallina A, Colombo R.
    Urol Int; 2017 Sep; 98(3):290-297. PubMed ID: 28142141
    [Abstract] [Full Text] [Related]

  • 28. Long-term outcomes of incidental prostate cancer at radical cystectomy.
    Packiam VT, Tsivian M, Avulova S, Sharma V, Tarrell R, Cheville JC, Frank I, Thompson RH, Tollefson MK, Gettman MT, Karnes RJ, Thapa P, Boorjian SA.
    Urol Oncol; 2020 Nov; 38(11):848.e17-848.e22. PubMed ID: 32624422
    [Abstract] [Full Text] [Related]

  • 29. Incidental Prostate Adenocarcinoma in Cystoprostatectomy Specimens: Partial Versus Complete Prostate Sampling.
    Filter ER, Gabril MY, Gomez JA, Wang PZT, Chin JL, Izawa J, Moussa M.
    Int J Surg Pathol; 2017 Aug; 25(5):414-420. PubMed ID: 28381150
    [Abstract] [Full Text] [Related]

  • 30. Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.
    Thomas C, Giesswein A, Hainz M, Stein R, Rubenwolf P, Roos FC, Neisius A, Nestler S, Hampel C, Jäger W, Wiesner C, Thüroff JW.
    Int Urol Nephrol; 2015 Nov; 47(11):1789-96. PubMed ID: 26377495
    [Abstract] [Full Text] [Related]

  • 31. Comparison between incidentally and clinically detected prostate cancer: implications for prostate cancer screening programs and focal therapy.
    Mazzucchelli R, Montironi R, Morichetti D, Scarpelli M, Lopez-Beltran A, Cheng L.
    Anal Quant Cytol Histol; 2010 Jun; 32(3):151-4. PubMed ID: 20701068
    [Abstract] [Full Text] [Related]

  • 32. Early prostate-specific antigen relapse after radical retropubic prostatectomy: prediction on the basis of preoperative and postoperative tumor characteristics.
    Graefen M, Noldus J, Pichlmeier U, Haese A, Hammerer P, Fernandez S, Conrad S, Henke R, Huland E, Huland H.
    Eur Urol; 1999 Jun; 36(1):21-30. PubMed ID: 10364651
    [Abstract] [Full Text] [Related]

  • 33. Prognostic Significance of Incidental Prostate Cancer at Radical Cystoprostatectomy for Bladder Cancer.
    Gakis G, Rink M, Fritsche HM, Graefen M, Schubert T, Hassan F, Chun FK, Brummeisl W, Fisch M, Burger M, Stenzl A, Renninger M.
    Urol Int; 2016 Jun; 97(1):42-8. PubMed ID: 26744841
    [Abstract] [Full Text] [Related]

  • 34. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens.
    Abdelhady M, Abusamra A, Pautler SE, Chin JL, Izawa JI.
    BJU Int; 2007 Feb; 99(2):326-9. PubMed ID: 17026595
    [Abstract] [Full Text] [Related]

  • 35. Impact of positive surgical margins on prostate-specific antigen failure after radical prostatectomy in adjuvant treatment-naïve patients.
    Ploussard G, Agamy MA, Alenda O, Allory Y, Mouracade P, Vordos D, Hoznek A, Abbou CC, de la Taille A, Salomon L.
    BJU Int; 2011 Jun; 107(11):1748-54. PubMed ID: 20883488
    [Abstract] [Full Text] [Related]

  • 36. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens.
    Winkler MH, Livni N, Mannion EM, Hrouda D, Christmas T.
    BJU Int; 2007 Mar; 99(3):554-8. PubMed ID: 17407514
    [Abstract] [Full Text] [Related]

  • 37. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy.
    Pettus JA, Al-Ahmadie H, Barocas DA, Koppie TM, Herr H, Donat SM, Dalbagni G, Reuter VE, Olgac S, Bochner BH.
    Eur Urol; 2008 Feb; 53(2):370-5. PubMed ID: 17689003
    [Abstract] [Full Text] [Related]

  • 38. [Incidence and clinicopathological characteristics of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens].
    Shen Q, Hu S, Li J, Wang JH, He Q.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug 18; 46(4):515-8. PubMed ID: 25131460
    [Abstract] [Full Text] [Related]

  • 39. PSA doubling time as a predictor of clinical progression after biochemical failure following radical prostatectomy for prostate cancer.
    Roberts SG, Blute ML, Bergstralh EJ, Slezak JM, Zincke H.
    Mayo Clin Proc; 2001 Jun 18; 76(6):576-81. PubMed ID: 11393495
    [Abstract] [Full Text] [Related]

  • 40. The periurethral glands do not significantly influence the serum prostate specific antigen concentration.
    Oesterling JE, Tekchandani AH, Martin SK, Bergstralh EJ, Reichstein E, Diamandis EP, Yemoto C, Stamey TA.
    J Urol; 1996 May 18; 155(5):1658-60. PubMed ID: 8627847
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.